Moderna, Inc. (NASDAQ: MRNA) is now covered by analysts at Berenberg Bank. They set a "hold" rating and a $42.00 price target on the stock.
Moderna, Inc. (NASDAQ: MRNA) was upgraded by analysts at Hsbc Global Res from a "hold" rating to a "strong-buy" rating.
Moderna, Inc. (NASDAQ: MRNA) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $69.00 price target on the stock, down previously from $115.00.
Moderna, Inc. (NASDAQ: MRNA) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating. They now have a $58.00 price target on the stock.
Moderna, Inc. (MRNA) Guggenheim's Inaugural Healthcare Innovation Conference (Transcript) [Seeking Alpha]